Skip to content Skip to navigation

The promise of ketamine as a rapid acting treatment for anxiety disorders

Wednesday, January 23, 2019 - 19:30

Low doses of ketamine seem able to dramatically improve obsessive-compulsive disorder, which has so far proved hard to treat. Carolyn Rodriguez’s lab at Stanford is seeking to understand how it works, with the hope of developing next-generation treatments that do not have ketamine’s side effects.

Carolyn Rodriguez
Assistant Professor
Psychiatry and Behavioral Sciences
Stanford University
This video is a part of:
IdeasLab | Davos 2019